GOAL

We have a profound belief in the fundamental value of our undertaking.
We are a research-based organization, dedicated to the future and to that which is truly useful.
Our activity is,guided by three paramount goals :

obviously, our main priority is to satisfy both the needs of the physicians prescribing our products and the patients benefiting from them

another essential goal is to contribute to medical progress through research : for us, research is at least as important as industry

but there is a third, vital objective, one all too often overlooked, which is to ensure that our employees may find fulfillment in, and by, their work.

This is much more than a guarantee of success: to us, it is a goal in its own right.

Largest independent French pharmaceutical group. Third French pharmaceutical group worldwide. Fourteenth pharmaceutical group in Europe. Twenty-seventh pharmaceutical group worldwide for ethical drugs. Worldwide sales of Servier drugs : 9.2 billion FRF, with exports accounting for 62 %. Most dynamic French pharmaceutical over the five last years with an increase in developpment of more than 9%.
Research and Development investment totaling one quarter of consolidated worldwide turnover.
Worldwide workforee of over 10 000, including 1800 in Research and Development